Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
We understand the clinical science, but just as importantly, we understand the financial and logistical hurdles patients face
DPP-4 inhibitors block the incretin-degrading function of DPP-4, thereby increasing the bioavailability of active GLP-1, which results in enhanced consumption-related insulin secretion
But there is currently no set release date
The goal is to obtain an FDA approval for a bremelanotide-based therapy for male ED, potentially offering the first new class of ED medication in over two decades
US$ 21.47
US$ 22.97
US$ 23.74
US$ 22.46
US$ 24.57
US$ 22.72
US$ 26.80
US$ 21.70
